Clinical trials sponsored by Peking University Third Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Peking University Third Hospital

• 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
  NCT07760012 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
  NCT07532434 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
  NCT06621056 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
  NCT07039552 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
  NCT06953622 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
  NCT06277531 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• Evaluation of the Effect of SURGICEL® Powder in TKA
  NCT06608992 · Phase: Phase 4 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
  NCT06513429 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Liraglutide Treatment in Obese Infertile PCOS Women
  NCT06742710 · Phase: Phase 4 · Ages: 20 Years to 40 Years · Sex: Female · 3 locations
• Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
  NCT06414655 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female · 11 locations
• Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
  NCT05638841 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prospective Cohort Study on Refractory Rheumatoid Arthritis
  NCT07126431 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
  NCT05947916 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: Female · 1 location
• Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
  NCT06828042 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS
  NCT06587698 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 40 Years · Sex: Female · 1 location

Common questions

How many trials is Peking University Third Hospital recruiting for?

Peking University Third Hospital is the lead sponsor of 15 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.